Chelsea R. Denue, PA

Chelsea Denue practices at Orchard Park Family Practice in Orchard Park, New York.

Chelsea Denue's NPI, 1508179045, was assigned on July 26, 2010. Chelsea Denue holds New York license 014114.

Chelsea Denue's primary practice is Orchard Park Family Practice, at 3670 S Benzing Rd, Orchard Park, NY 14127 in Erie County. The practice phone is (716) 662-5357.

Chelsea Denue's primary practice is Orchard Park Family Practice in Orchard Park, New York. Chelsea Denue is also affiliated with Sisters of Charity Hospital. The medical group on file is Orchard Park Family Practice, PC. Dmand AI also links Chelsea Denue to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chelsea Denue practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Chelsea Denue's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Chelsea Denue is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Chelsea Denue is licensed in New York.

Dmand AI lists chronic kidney disease, ear infection, lower back pain, muscle pain, fibromyalgia, and limb pain, pneumonia, tobacco use, upper respiratory infection (URI) and UTI among the conditions Chelsea Denue treats.

CMS data shows 57 Medicare services from Chelsea Denue across 3 procedure codes in 2024, for 43 Medicare patients. Medicare paid $3,526 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Chelsea Denue in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Chelsea Denue's median patient age at 44, with 68% women.

In 2024, Chelsea Denue wrote 1,164 Medicare Part D claims for 235 patients. 88% of them were for generic drugs. CMS names the drug for 653 of them, across 26 drugs with 11 or more claims each, at $39,687 in total drug cost.

Chelsea Denue accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Chelsea Denue from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Organon LLC paid the most, $45.